HOME >> BIOLOGY >> NEWS
Good bacteria trigger proteins to protect the gut

New studies by Howard Hughes Medical Institute researchers indicate that the millions of beneficial bacteria living in the human gut may actually be helping to stave off injury to the lining of the intestines.

According to the researchers, their unexpected findings suggest that the practice of giving antibiotics to cancer patients to prevent infections might render the gut more vulnerable to damage a danger that might be overcome by administering substances that mimic the protective presence of gut bacteria. The findings may also revise thinking about the treatment of inflammatory bowel disease (IBD), in which the intestine is believed to mount an inflammatory response to benign, or commensal, bacteria.

The researchers, led by Howard Hughes Medical Institute investigator Ruslan Medzhitov at Yale University School of Medicine, reported their studies in the July 23, 2004, issue of the journal Cell.

"Until now, almost everything we knew about the benefits of commensal bacteria had to do with their biological activity," said Medzhitov. "They metabolize nutrients to enable us to absorb them more readily. They aid in the early development of the gastrointestinal system. And they produce factors that prevent colonization by pathogenic bacteria. Our work, however, has revealed a role that is quite different."

Specifically, Medzhitov and his colleagues discovered that beneficial bacteria trigger proteins called Toll-like receptors (TLRs) to maintain the health of intestinal epithelial cells and to activate machinery that responds to injury. Previously, TLRs were thought to function strictly as assassins, recognizing molecules on the surface of pathogenic bacteria and triggering the innate immune system to attack.

"It's always been a major paradox that our immune system evolved to recognize pathogenic microorganisms and to react to them with a powerful, des
'"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
22-Jul-2004


Page: 1 2 3 4

Related biology news :

1. Researchers find color sensitive atomic switch in bacteria
2. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
3. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
4. Scientists discover potential new way to control drug-resistant bacteria
5. 22nd amino acid synthesized and added to genetic code of e. coli bacteria
6. Missing genes may help explain why plague bacteria are so deadly
7. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
8. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
9. UC Irvine scientists to develop vaccine to combat bioterrorism threat from deadly bacteria
10. UV light, coatings reduce bacterial adhesion up to 50 percent
11. PCB breakdown in rivers depends on sediment-specific bacteria, find Carnegie Mellon U. scientists

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... , ... July 08, 2020 , ... ... Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • ... comparability study, but what is the most effective way to complete one? Will ...
(Date:7/2/2020)... , ... July 02, 2020 ... ... Systems, B.V. (MBS) has announced a publication detailing the use of its ... transcription polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast ...
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled for the ... of Care Testing solutions (POCT). Check local listings for more info. , Today, the ... and are shipped to labs throughout the country. Results are then available several days ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... June 30, 2020 , ... ... data insights, today announced that the launch of a new clinical ... data about the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... cancer, today announced the company has entered a license agreement with Roswell Park ... Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel medical ...
(Date:6/23/2020)... Fla. (PRWEB) , ... June 23, 2020 , ... ... enabled solutions in complex indoor environments, announced today that Derek Fournier has been ... role of Chairman of the Board, effective immediately. , “DeCurtis Corporation has ...
(Date:6/23/2020)... , ... June 23, 2020 , ... ... CNS therapies, today announced that it has filed an Investigational New Drug application ... 2b clinical trial of its lead drug candidate NBTX-001 in patients with panic ...
Breaking Biology Technology:
Cached News: